Big Pharma Braces For Modest Financial And Clinical Trial Disruption In Eastern Europe
Executive Summary
Companies like Merck, Pfizer and J&J expressed concern for employees and patients in Ukraine and Russia, and said they expect only a modest negative impact on revenues and clinical trials coming from business disruption in the region.